Dextera Biosciences
Julia Williams is currently the Director of Finance at Dextera Biosciences. Prior to this role, Julia served as an Accounting Controller & Finance Director at Murdock Martell and held various finance positions at Central Elementary School, Applied Biosystems, The Smiths Snackfood Co Pty Ltd, and United Biscuits. Julia holds a Bachelor of Business Administration (B.B.A.) in Finance, General, is a Certified Public Accountant (CPA), and is a member of The Chartered Institute of Management Accountants. Julia's extensive experience in finance roles has equipped their with valuable skills and expertise in financial management.
This person is not in any teams
This person is not in any offices
Dextera Biosciences
Dextera Biosciences is developing a new category of drugs, Synthetic D-Proteins, to overcome the limitations of current drug modalities. Synthetic D-Proteins exhibit antibody-like specificity to a single therapeutic target but with the broad distribution of small molecules, all while being otherwise “invisible” to the rest of the body. The consequences are that we can deliver sustained antibody-like activity specifically to interstitial targets, enable oral delivery with complete metabolic stability, and extend therapeutic durability with no immunogenicity. We are focusing on debilitating diseases where significant unmet need remains due to the limitations of current drugs.